a challenging percutaneous transaxillary tavr
play

A CHALLENGING PERCUTANEOUS TRANSAXILLARY TAVR Flavien Vincent MD, - PowerPoint PPT Presentation

Jun 03, 2023 •153 likes •327 views

A CHALLENGING PERCUTANEOUS TRANSAXILLARY TAVR Flavien Vincent MD, PhD abcd ; Cdric Delhaye Md a ; Philippe Gnreux MD f ; Francis Juthier MD, PhD e , Richard Azzaoui, MD e ; Hugues Spillemaeker a , Eric Van Belle MD, PhD abcd a CHU Lille,

  1. A CHALLENGING PERCUTANEOUS TRANSAXILLARY TAVR Flavien Vincent MD, PhD abcd ; Cédric Delhaye Md a ; Philippe Généreux MD f ; Francis Juthier MD, PhD e , Richard Azzaoui, MD e ; Hugues Spillemaeker a , Eric Van Belle MD, PhD abcd a CHU Lille, Cardiologie interventionnelle, France; b Inserm, U1011, Lille, France; c Univ. Lille, U1011 - EGID, Lille, France; d Institut Pasteur de Lille, France; e CHU Lille, Chirurgie cardiaque et vasculaire, France; f Morristown medical center, NJ, USA & CRF, NY, USA 30-31 Janvier 1 er Février 2019

  2. 80 YO MALE, SEVERE AORTIC STENOSIS Right iliac : 3,5mm •LVEF 60% •CAD : PCI RCA & Cx (2015) •Atrial fibrillation •Chronic Kidney disease • Severe PAD: Left iliac : 3,2mm Hostile, calcified Calcified femoral anterior wall ++ femoral access 30-31 Janvier 1 er Février 2019

  3. SCREENING FOR ALTERNATIVE ACCESS : TOO SMALL CAROTID ARTERIES Right carotid : 3,0mm 30-31 Janvier 1 er Février 2019 Left carotid : 3,2mm

  4. SCREENING FOR ALTERNATIVE ACCESS : SUITABLE FOR LEFT TRANSAXILLARY ACCESS Anticipated issues : • Small diameter, subclavian tortuosity & clusters of calcifications • Suitable for Evolut R with In-line Sheath 30-31 Janvier 1 er Février 2019

  5. PERCUTANEOUS TRANSAXILLARY ACCESS • Axillary Angiography via 9 Fr Right femoral access • Safety 0,018 wire from right leg to left arm 30-31 Janvier 1 er Février 2019

  6. PERCUTANEOUS TRANSAXILLARY ACCESS • Angio / Fluo / Ultrasound-guided puncture 30-31 Janvier 1 er Février 2019

  7. PERCUTANEOUS TRANSAXILLARY ACCESS • X2 pre-closing w/ proglide • Valve crossing and predilatation with 14Fr sheath 30-31 Janvier 1 er Février 2019

  8. DIFFICULTIES FOR CROSSING SUBCLAVIAN TORTUOSITY Crossing difficulties with Boston Amplatz super stiff wire 30-31 Janvier 1 er Février 2019

  9. DIFFICULTIES FOR CROSSING SUBCLAVIAN TORTUOSITY Success after reorientation in-line Crossing difficulties with Boston sheath Amplatz super stiff wire 30-31 Janvier 1 er Février 2019

  10. DIFFICULTIES FOR CROSSING SUBCLAVIAN TORTUOSITY 30-31 Janvier 1 er Février 2019

  11. SAFETY WIRE PULLED OUT BY VALVE SHEATH • Wire gets dragged on by inline-sheath into ascending aorta • Risk of jailed wire after valve deployment • Risk of losing safety wire 30-31 Janvier 1 er Février 2019

  12. SAFETY WIRE PULLED OUT BY VALVE SHEATH JR4 to reduce slack and jump up the safety wire Successful Evolut R 29mm valve implantation 30-31 Janvier 1 er Février 2019

  13. DRY ARTERY CLOSURE � Inline sheath withdrawal protected by balloon tamponade � Percutaneous closure with proglide X2 30-31 Janvier 1 er Février 2019

  14. FINAL ANGIOGRAM • Final angio revealing subclavian artery dissection • Conservative management 30-31 Janvier 1 er Février 2019

  15. FOLLOW-UP • Normal Axillary & Subclavian Ultrasound exam • No further event 30-31 Janvier 1 er Février 2019

  16. TAKE HOME • Thorough planification mandatory • Require Basic peripheral skills • Safe (full percutaneous management if preclosing device failure) • Know the limits : Not for all (anatomic issues : obese, small diameter, extreme tortuosity and calcifications); Require 2 nd access • Reduce the threshold for alternative access • #1 alternative access in our team 30-31 Janvier 1 er Février 2019

Recommend

Disclosures I have nothing to disclose 1 9/21/2015 Why is TAVR Important to You?

Disclosures I have nothing to disclose 1 9/21/2015 Why is TAVR Important to You?

9/21/2015 Anesthesia For TAVR Lundy J. Campbell, MD Professor of Clinical Anesthesia Chief, Division of Adult Cardiothoracic Anesthesia Disclosures I have nothing to disclose 1 9/21/2015 Why is TAVR Important to You? Ability to

338 views • 9 slides
PRAVEEN PANGULURI, MD OCTOBER 29, 2019 PRE TAVR ECHO PRE CT MEASUREMENTS Annulus area: 398 mm2

PRAVEEN PANGULURI, MD OCTOBER 29, 2019 PRE TAVR ECHO PRE CT MEASUREMENTS Annulus area: 398 mm2

PRAVEEN PANGULURI, MD OCTOBER 29, 2019 PRE TAVR ECHO PRE CT MEASUREMENTS Annulus area: 398 mm2 LVOT area: 366 mm2 Dimensions: 19x27mm Dimensions: 18x27mm PRE CT MEASUREMENTS VALVE DEPLOYMENT IMMEDIATE POST TAVR IMMEDIATE POST TAVR TTE

337 views • 11 slides
Is Percutaneous Closure of PFO Is Percutaneous Closure of PFO indicated for Patients with

Is Percutaneous Closure of PFO Is Percutaneous Closure of PFO indicated for Patients with

Is Percutaneous Closure of PFO Is Percutaneous Closure of PFO indicated for Patients with indicated for Patients with Cryptogenic Stroke ? Cryptogenic Stroke ? Shunichi Homma, MD FACC Shunichi Homma, MD FACC M.M. Hatch Professor of Medicine

2.05k views • 147 slides
Percutaneous POSE What is its real worth? David Murray MD FRCS Consultant Vascular Surgeon

Percutaneous POSE What is its real worth? David Murray MD FRCS Consultant Vascular Surgeon

Percutaneous POSE What is its real worth? David Murray MD FRCS Consultant Vascular Surgeon Manchester University Hospital NHS TRust Percutaneous POSE Preclose technique FDA 0.07 0.32 inches The Perclose ProGlide vascular closure

548 views • 31 slides
after TAVR Key Messages from NeuroARC Alexandra Lansky, MD Professor of Medicine, Section of

after TAVR Key Messages from NeuroARC Alexandra Lansky, MD Professor of Medicine, Section of

The Compelling Saga of Strokes after TAVR Key Messages from NeuroARC Alexandra Lansky, MD Professor of Medicine, Section of Cardiology Yale School of Medicine Disclosure Statement of Financial Interest Within the past 12 months, I or my

578 views • 18 slides
Same Day Discharge after Percutaneous Coronary Intervention Nurses Role in an

Same Day Discharge after Percutaneous Coronary Intervention Nurses Role in an

Same Day Discharge after Percutaneous Coronary Intervention Nurses Role in an Inter-Professional Practice Change Gertrude Kent RN-BC, BSN Maine Medical Center Maine Nursing Summit 3/24/2016 Objectives To understand and describe the

593 views • 27 slides
Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable,

Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable,

Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients Susheel Kodali, MD on behalf of The PARTNER Trial Investigators ACC 2015 | San Diego | March 15,

855 views • 43 slides
Will New TAVR Systems or Accessory Devices Make a Difference? Samir Kapadia, MD Professor of

Will New TAVR Systems or Accessory Devices Make a Difference? Samir Kapadia, MD Professor of

Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference? Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Cleveland Clinic All faculty disclosures are

329 views • 28 slides
1 PERCUTANEOUS AVF HAS NOTHING TO OFFER OR NOT TOO MUCH Dr Thierry POURCHEZ BETHUNE FRANCE

1 PERCUTANEOUS AVF HAS NOTHING TO OFFER OR NOT TOO MUCH Dr Thierry POURCHEZ BETHUNE FRANCE

1 PERCUTANEOUS AVF HAS NOTHING TO OFFER OR NOT TOO MUCH Dr Thierry POURCHEZ BETHUNE FRANCE PARIS INSTITUT MONTSOURIS 14 september 2018 WHAT NEED THE NEPHROLOGY TEAM? A GOOD FISTULA THAT MEETS THE RULE OF 6s When the fistula is

708 views • 39 slides
Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery Eric L. Eisenstein, DBA Duke Clinical Research Ins8tute On behalf of

226 views • 12 slides
Overview Percutaneous Paravalvular Leak Closure When it works and when it doesnt

Overview Percutaneous Paravalvular Leak Closure When it works and when it doesnt

10/1/16 Overview Percutaneous Paravalvular Leak Closure When it works and when it doesnt Disclosures: Nothing to disclose. Off label use of devices. Christian Spies, MD Interventional Cardiologist The Queens Center for

794 views • 21 slides
Strokes After TAVR Multi-factorial Origin, Incidence (past and present), and Management

Strokes After TAVR Multi-factorial Origin, Incidence (past and present), and Management

Strokes After TAVR Multi-factorial Origin, Incidence (past and present), and Management Considerations (present and future) Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Cleveland Clinic Conflict

710 views • 42 slides
Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison Between Hospitals

Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison Between Hospitals

PRIMARY PCI in MASSACHUSETTS Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison Between Hospitals With and Without Cardiac Surgery On-Site Ather Anis, Sharon-Lise T. Normand, Robert E. Wolf, Ann Lovett, Laura Mauri,

557 views • 20 slides
Reinventing Yourself: How to Add New Procedures ( Peripheral, Carotid, TAVR, Structural) Tony

Reinventing Yourself: How to Add New Procedures ( Peripheral, Carotid, TAVR, Structural) Tony

Reinventing Yourself: How to Add New Procedures ( Peripheral, Carotid, TAVR, Structural) Tony Das MD, FACC Director, Peripheral Interventions Texas Health, Presbyterian Hospital Dallas, Texas Faculty Disclosure Tony Das, MD For the 12

415 views • 26 slides
Antithrombotic Strategies Post-TAVR Amit N. Vora, MD MPH Structural Interventional Cardiologist

Antithrombotic Strategies Post-TAVR Amit N. Vora, MD MPH Structural Interventional Cardiologist

Antithrombotic Strategies Post-TAVR Amit N. Vora, MD MPH Structural Interventional Cardiologist UPMC Pinnacle, Harrisburg PA Disclosures Research funding BMS Education funding: Medtronic Background The initial pivotal trials used

551 views • 15 slides
Coronaries Behind Bars: Angiography & In Interv rvention Following TAVR Faisal Latif MD,

Coronaries Behind Bars: Angiography & In Interv rvention Following TAVR Faisal Latif MD,

Coronaries Behind Bars: Angiography & In Interv rvention Following TAVR Faisal Latif MD, FSCAI, FACC Director Cardiac Catheterization Lab, VAMC Associate Professor of Medicine Governor, Oklahoma Chapter of ACC Associate Program Director,

395 views • 24 slides
Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous

Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous

Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention Cardiac Magnetic Resonance Substudy of the AIDA STEMI trial Holger Thiele, MD; Jochen Whrle, MD; Henning Suenkel, BSc;

453 views • 24 slides
SEX DIFFERENCES IN OUTCOMES OF CARDIOGENIC SHOCK REQUIRING TEMPORARY PERCUTANEOUS MECHANICAL

SEX DIFFERENCES IN OUTCOMES OF CARDIOGENIC SHOCK REQUIRING TEMPORARY PERCUTANEOUS MECHANICAL

SEX DIFFERENCES IN OUTCOMES OF CARDIOGENIC SHOCK REQUIRING TEMPORARY PERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT Katia Bravo-Jaimes 1 , Miluska O. Mejia 2 , Yelin Zhou 1, Abijheet Dhoble 1 1 University of Texas Health Science Center, Division

69 views • 5 slides
Valve-in-Valve TAVR David J. Cohen, M.D., M.Sc. Director, Cardiovascular Research Saint- Lukes

Valve-in-Valve TAVR David J. Cohen, M.D., M.Sc. Director, Cardiovascular Research Saint- Lukes

Bioprosthetic Valve Fracture for Optimizing Results of Valve-in-Valve TAVR David J. Cohen, M.D., M.Sc. Director, Cardiovascular Research Saint- Lukes Mid America Heart Institute Professor of Medicine University of Missouri-Kansas City

389 views • 23 slides
after TAVR and SAVR Diagnostic Considerations and NeuroARC Alexandra Lansky, MD Professor of

after TAVR and SAVR Diagnostic Considerations and NeuroARC Alexandra Lansky, MD Professor of

The Compelling Saga of Strokes after TAVR and SAVR Diagnostic Considerations and NeuroARC Alexandra Lansky, MD Professor of Medicine, Section of Cardiology Yale School of Medicine Dis isclosures Speaker's name: Alexandra Lansky I have

197 views • 16 slides
TAVR in Low Risk Patients: Case Presentations Chad Kliger MD MS Western Regional Director,

TAVR in Low Risk Patients: Case Presentations Chad Kliger MD MS Western Regional Director,

TAVR in Low Risk Patients: Case Presentations Chad Kliger MD MS Western Regional Director, Structural Heart Disease Assistant Professor of Cardiology, Hofstra School of Medicine Lenox Hill Heart and Lung, Northwell Health Disclosures Within

659 views • 20 slides
Percutaneous Repair with the MitraClip Device for Severe Secondary Mitral Regurgitation Pr Jean

Percutaneous Repair with the MitraClip Device for Severe Secondary Mitral Regurgitation Pr Jean

Percutaneous Repair with the MitraClip Device for Severe Secondary Mitral Regurgitation Pr Jean Franois OBADIA - LYON on behalf of the MITRA-FR Investigators Declaration of Interest Research grant : Abbott, Neochord Consulting fee :

626 views • 29 slides
Current and Future Management of Symptomatic Aortic Stenosis Alexander (Sandy) Dick, MD

Current and Future Management of Symptomatic Aortic Stenosis Alexander (Sandy) Dick, MD

Current and Future Management of Symptomatic Aortic Stenosis Alexander (Sandy) Dick, MD Disclosures None pertaining to this talk Technique vs Technology SAVR vs TAVR TAVR and SAVR Equivalency? Mortality/Stroke Morbidity

741 views • 59 slides
Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: The

Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: The

Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: The COLCHICINE-PCI Randomized Trial Binita Shah, MD, MS on behalf of the COLCHICINE-PCI investigators Associate Director of Research, Cardiac Cath Lab

810 views • 24 slides

More recommend